News By Tag
News By Location
Follow on Google News
Sepsis Diagnostics Market Statistics 2021 : Growth, Forecast and Competitive Analysis
Sepsis is a life-threatening medical emergency. It is body's response to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure.
As per WHO, globally, sepsis touches around 49 million people each year. Early diagnosis of sepsis is serious for patient outcomes. However, diagnosing sepsis is not an easy task as there is no particular symptom or sign that are directly related to the disease.
Growth of Rapid Diagnostic Tests/Point-
Currently, clinicians possess limited technology needed to conduct multiplexed and fully quantitative diagnostic tests at the point of care with high sensitivity. Citing the need for rapid diagnostic tests, several research universities and product manufacturers are developing innovative rapid diagnostic tests/point-
"With sepsis, timing is the key. Advancements in diagnostic speed, range, and accuracy are critical for addressing the continued rise in sepsis cases and deaths. Advent of new rapid diagnostic tests for sepsis can save thousands of lives." - Senior Director, Leading In-Vitro Diagnostics Manufacturer, United States
Get Customized Report on Sepsis Diagnostics Market @ https://meditechinsights.com/
Competitive Landscape Analysis: Sepsis Diagnostics Market
The Sepsis Diagnostics market is marked by presence of both established players such as bioMérieux, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation and innovative firms such as Seegene Inc., Axis-Shield Diagnostics, Immunexpress, and others.
For More Detailed Insights, Contact Us @ https://meditechinsights.com/
About Medi-Tech Insights:
Medi-Tech Insights is a healthcare-focused business research & insights firm. We have successfully completed 100+ projects in Healthcare IT, MedTech, Medical Devices & Pharma Services in the areas of due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry leading CXO, VPs and key demand/supply side decision-makers.
Associate, Medi-Tech Insights
+32 498 86 80 79